Skip to content
Recall Observatory FDA recall evidence

Drug product

Ibuprofen Tablets USP 800 mg, a) 100 tablet (NDC 42582-113-10) and b) 500 tablet (NDC 42582-113-18) bottles, Rx, Distributed by; Bi-Coastal Pharma International, Shrewsbury, NJ, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India

D-0693-2018

January 11, 2018

Class II

Product summary

Firm
Time-Cap Laboratories, Inc.
Event
Event 79349
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0693-2018

Official wording

Reason: CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Code information: a) C140C, exp 2/18; b) D049C, D050C, D051C, C142C, C137C, C138C, C141C, exp 2/18; D073C, D074C, exp 3/18

Distribution pattern: Nationwide.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations